Evidence map›Paper›PMID 25740824›Full record

ArticleCarcinogenesis2015

Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.

Kazuhiro Yamanoi, Eri Arai, Ying Tian, Yoriko Takahashi, Sayaka Miyata, Hiroki Sasaki, Fumiko Chiwaki, Hitoshi Ichikawa, Hiromi Sakamoto, Ryoji Kushima and 4 more

Abstract readComparative Study
In one paragraph

Article in Carcinogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TiORSC advances · 2019
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kazuhiro YamanoiDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan, Department of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Eri AraiDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan, earai@ncc.go.jp.
Ying TianDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Yoriko TakahashiBioscience Department, Business Development Division, Mitsui Knowledge Industry Co., Ltd., Tokyo 105-6215, Japan.
Sayaka MiyataBioscience Department, Business Development Division, Mitsui Knowledge Industry Co., Ltd., Tokyo 105-6215, Japan.
Hiroki SasakiDepartment of Translational Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Fumiko ChiwakiDepartment of Translational Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Hitoshi IchikawaDivision of Genetics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Hiromi SakamotoDivision of Genetics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Ryoji KushimaDepartment of Pathology and Clinical Laboratories, Pathology Division, National Cancer Center Hospital, Tokyo 104-0045, Japan and.
Hitoshi KataiDepartment of Gastric Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Teruhiko YoshidaDivision of Genetics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Michiie SakamotoDepartment of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yae KanaiDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Keio University · JPMitsui (Japan) · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to clarify the significance of DNA methylation alterations during gastric carcinogenesis. Single-CpG resolution genome-wide DNA methylation analysis using the Infinium assay was performed on 109 samples of non-cancerous gastric mucosa (N) and 105 samples of tumorous tissue (T). DNA methylation alterations in T samples relative to N samples were evident for 3861 probes. Since N can be at the precancerous stage according to the field cancerization concept, unsupervised hierarchical clustering based on DNA methylation levels was performed on N samples (βN) using the 3861 probes. This divided the 109 patients into three clusters: A (n = 20), B1 (n = 20), and B2 (n = 69). Gastric carcinomas belonging to Cluster B1 showed tumor aggressiveness more frequently than those belonging to Clusters A and B2. The recurrence-free and overall survival rates of patients in Cluster B1 were lower than those of patients in Clusters A and B2. Sixty hallmark genes for which βN characterized the epigenetic clustering were identified. We then focused on DNA methylation levels in T samples (βT) of the 60 hallmark genes. In 48 of them, including the ADAM23, OLFM4, AMER2, GPSM1, CCL28, DTX1 and COL23A1 genes, βT was again significantly correlated with tumor aggressiveness, and the recurrence-free and/or overall survival rates. Multivariate analyses revealed that βT was a significant prognostic factor, being independent of clinicopathological parameters. These data indicate that DNA methylation profiles at the precancerous stage may be inherited by gastric carcinomas themselves, thus determining tumor aggressiveness and patient outcome.

Indexed as

DNA MethylationGene Expression Regulation, NeoplasticAdultAgedAged, 80 and overBiomarkers, TumorCase-Control StudiesEpigenesis, GeneticFemaleFollow-Up StudiesGastric MucosaHumansImmunoenzyme TechniquesMaleMiddle AgedNeoplasm GradingBiomarkers, TumorRNA, Messenger

Identifiers

PMID25740824
PMCPMC4417340
OpenAlexW2334704543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.